Encapsulation and micronization effectively improve orange beverage flavanone bioavailability in humans.
Identifieur interne : 001828 ( Ncbi/Curation ); précédent : 001827; suivant : 001829Encapsulation and micronization effectively improve orange beverage flavanone bioavailability in humans.
Auteurs : María Tomás-Navarro [Espagne] ; Fernando Vallejo ; Francisco Borrego ; Francisco A. Tomás-BarberánSource :
- Journal of agricultural and food chemistry [ 1520-5118 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , chemistry : Hesperidin.
- analysis : Beverages.
- chemistry : Citrus sinensis.
- methods : Drug Compounding.
- chemical , pharmacokinetics : Hesperidin.
- Adult, Biological Availability, Humans, Male, Middle Aged, Particle Size.
Abstract
The effect of hesperidin encapsulation and particle size reduction on hesperetin bioavailability was assessed after the intake of orange flavanone beverages. Hesperidin micronization (5.1 μm) increased flavanone's bioavailability 2-fold compared to conventional hesperidin (32.8 μm). Gum Arabic encapsulated hesperidin, with enhanced dispersion in water, also showed increased bioavailability despite having a higher particle size than conventional hesperidin (74.2 μm), showing that flavanone dispersion also enhances its bioavailability. The bioavailability of micronized hesperetin was also evaluated to overcome the need for gut microbiota rhamnosidase hydrolysis. When volunteers were stratified for their flavanone excretion capability, differences among treatments were better observed. The treatments used to increase solubility and decrease particle size to facilitate the interaction with intestinal cells and gut microbiota enhanced bioavailabilty especially in high (9.2 ± 1.5 mg) and medium (5.5 ± 0.3 mg) flavanone excretors. On the contrary, micronized hesperetin bioavailability was particularly high in the case of low excretors (4.3 ± 0.6 mg), showing that the low excretion in these volunteers should be associated with the lack of the appropriate microbiota to release hesperetin from hesperidin. Not all of the low excretors, however, reached the excretion levels of high excretors when hesperetin was supplied, suggesting that differences in intestinal transporters of the volunteers could also affect the flavanone excretion rates observed.
DOI: 10.1021/jf502933v
PubMed: 25200135
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000292
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000292
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000292
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001828
Links to Exploration step
pubmed:25200135Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Encapsulation and micronization effectively improve orange beverage flavanone bioavailability in humans.</title>
<author><name sortKey="Tomas Navarro, Maria" sort="Tomas Navarro, Maria" uniqKey="Tomas Navarro M" first="María" last="Tomás-Navarro">María Tomás-Navarro</name>
<affiliation wicri:level="2"><nlm:affiliation>Research Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS-CSIC , Campus de Espinardo, 30100 Murcia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Research Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS-CSIC , Campus de Espinardo, 30100 Murcia</wicri:regionArea>
<placeName><region nuts="2" type="communauté">Région de Murcie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vallejo, Fernando" sort="Vallejo, Fernando" uniqKey="Vallejo F" first="Fernando" last="Vallejo">Fernando Vallejo</name>
</author>
<author><name sortKey="Borrego, Francisco" sort="Borrego, Francisco" uniqKey="Borrego F" first="Francisco" last="Borrego">Francisco Borrego</name>
</author>
<author><name sortKey="Tomas Barberan, Francisco A" sort="Tomas Barberan, Francisco A" uniqKey="Tomas Barberan F" first="Francisco A" last="Tomás-Barberán">Francisco A. Tomás-Barberán</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25200135</idno>
<idno type="pmid">25200135</idno>
<idno type="doi">10.1021/jf502933v</idno>
<idno type="wicri:Area/PubMed/Corpus">000292</idno>
<idno type="wicri:Area/PubMed/Curation">000292</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000292</idno>
<idno type="wicri:Area/Ncbi/Merge">001828</idno>
<idno type="wicri:Area/Ncbi/Curation">001828</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Encapsulation and micronization effectively improve orange beverage flavanone bioavailability in humans.</title>
<author><name sortKey="Tomas Navarro, Maria" sort="Tomas Navarro, Maria" uniqKey="Tomas Navarro M" first="María" last="Tomás-Navarro">María Tomás-Navarro</name>
<affiliation wicri:level="2"><nlm:affiliation>Research Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS-CSIC , Campus de Espinardo, 30100 Murcia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Research Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS-CSIC , Campus de Espinardo, 30100 Murcia</wicri:regionArea>
<placeName><region nuts="2" type="communauté">Région de Murcie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vallejo, Fernando" sort="Vallejo, Fernando" uniqKey="Vallejo F" first="Fernando" last="Vallejo">Fernando Vallejo</name>
</author>
<author><name sortKey="Borrego, Francisco" sort="Borrego, Francisco" uniqKey="Borrego F" first="Francisco" last="Borrego">Francisco Borrego</name>
</author>
<author><name sortKey="Tomas Barberan, Francisco A" sort="Tomas Barberan, Francisco A" uniqKey="Tomas Barberan F" first="Francisco A" last="Tomás-Barberán">Francisco A. Tomás-Barberán</name>
</author>
</analytic>
<series><title level="j">Journal of agricultural and food chemistry</title>
<idno type="eISSN">1520-5118</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Beverages (analysis)</term>
<term>Biological Availability</term>
<term>Citrus sinensis (chemistry)</term>
<term>Drug Compounding (methods)</term>
<term>Hesperidin (chemistry)</term>
<term>Hesperidin (pharmacokinetics)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Particle Size</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Hesperidin</term>
</keywords>
<keywords scheme="MESH" qualifier="analysis" xml:lang="en"><term>Beverages</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Citrus sinensis</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Compounding</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Hesperidin</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Biological Availability</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Particle Size</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effect of hesperidin encapsulation and particle size reduction on hesperetin bioavailability was assessed after the intake of orange flavanone beverages. Hesperidin micronization (5.1 μm) increased flavanone's bioavailability 2-fold compared to conventional hesperidin (32.8 μm). Gum Arabic encapsulated hesperidin, with enhanced dispersion in water, also showed increased bioavailability despite having a higher particle size than conventional hesperidin (74.2 μm), showing that flavanone dispersion also enhances its bioavailability. The bioavailability of micronized hesperetin was also evaluated to overcome the need for gut microbiota rhamnosidase hydrolysis. When volunteers were stratified for their flavanone excretion capability, differences among treatments were better observed. The treatments used to increase solubility and decrease particle size to facilitate the interaction with intestinal cells and gut microbiota enhanced bioavailabilty especially in high (9.2 ± 1.5 mg) and medium (5.5 ± 0.3 mg) flavanone excretors. On the contrary, micronized hesperetin bioavailability was particularly high in the case of low excretors (4.3 ± 0.6 mg), showing that the low excretion in these volunteers should be associated with the lack of the appropriate microbiota to release hesperetin from hesperidin. Not all of the low excretors, however, reached the excretion levels of high excretors when hesperetin was supplied, suggesting that differences in intestinal transporters of the volunteers could also affect the flavanone excretion rates observed.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001828 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001828 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Bois |area= OrangerV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:25200135 |texte= Encapsulation and micronization effectively improve orange beverage flavanone bioavailability in humans. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:25200135" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a OrangerV1
This area was generated with Dilib version V0.6.25. |